Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001398344-25-009599
Filing Date
2025-05-15
Accepted
2025-05-15 14:07:36
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 5605
  Complete submission text file 0001398344-25-009599.txt   7476
Mailing Address 1201 N CALVERT STREET BALTIMORE MD 21202
Business Address 1201 N CALVERT ST BALTIMORE MD 21201 4108373234
BROWN CAPITAL MANAGEMENT LLC (Filed by) CIK: 0000885062 (see all company filings)

EIN.: 521304372 | State of Incorp.: MD | Fiscal Year End: 1231
Type: SCHEDULE 13G/A

Mailing Address 47215 LAKEVIEW BOULEVARD FREMONT CA 94538
Business Address 47215 LAKEVIEW BOULEVARD FREMONT CA 94538 (877) 922-9835
Cytek Biosciences, Inc. (Subject) CIK: 0001831915 (see all company filings)

EIN.: 472547526 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-92754 | Film No.: 25951336
SIC: 3826 Laboratory Analytical Instruments
(CF Office: 08 Industrial Applications and Services)